<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Obstetrics and Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics and Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство и гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0300-9092</issn><issn publication-format="electronic">2412-5679</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">248912</article-id><article-id pub-id-type="doi">10.18565/aig.2020.5.132-138</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">THE IMPACT OF DIFFERENT SURGICAL TREATMENTS FOR UTERINE FIBROIDS ON OVARIAN RESERVE INDICES</article-title><trans-title-group xml:lang="ru"><trans-title>ВЛИЯНИЕ РАЗЛИЧНЫХ МЕТОДОВ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ МИОМЫ МАТКИ НА ПОКАЗАТЕЛИ ОВАРИАЛЬНОГО РЕЗЕРВА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>VYSOTSKY</surname><given-names>Maxim M.</given-names></name><name xml:lang="ru"><surname>ВЫСОЦКИЙ</surname><given-names>Максим Маркович</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, PhD, Professor of the Department of Endoscopic Surgery, Head of the course «Endoscopic surgery in gynecology»</p></bio><bio xml:lang="ru"><p>д.м.н., профессор кафедры эндоскопической хирургии, руководитель курса «Эндоскопическая хирургия в гинекологии».</p></bio><email>visotsky-gyn@mtu-net.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>KURANOV</surname><given-names>Ivan I.</given-names></name><name xml:lang="ru"><surname>КУРАНОВ</surname><given-names>Иван Иванович</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, Gynecologist of the 22nd Gynecological Department</p></bio><bio xml:lang="ru"><p>врач-гинеколог 22 гинекологического отделения</p></bio><email>Doktorkuranov@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>NEVZOROV</surname><given-names>Oleg B.</given-names></name><name xml:lang="ru"><surname>НЕВЗОРОВ</surname><given-names>Олег Борисович</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, PhD, Associate Professor of the Department of Obstetrics and Gynecology</p></bio><bio xml:lang="ru"><p>к.м.н., доцент кафедры акушерства и гинекологии</p></bio><email>nev266l@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Московский государственный медико-стоматологический университет имени А.И. Евдокимова» Министерства здравоохранения Российской Федерации</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">S.P. Botkin City Clinical Hospital, Moscow Healthcare Department</institution></aff><aff><institution xml:lang="ru">Городская клиническая больница имени С.П. Боткина Департамента здравоохранения города Москвы</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-05-15" publication-format="electronic"><day>15</day><month>05</month><year>2020</year></pub-date><issue>5</issue><issue-title xml:lang="en">NO5 (2020)</issue-title><issue-title xml:lang="ru">№5 (2020)</issue-title><fpage>132</fpage><lpage>138</lpage><history><date date-type="received" iso-8601-date="2023-02-18"><day>18</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, ООО «Бионика Медиа»</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0300-9092/article/view/248912">https://journals.eco-vector.com/0300-9092/article/view/248912</self-uri><abstract xml:lang="en"><p>Objective. To investigate ovarian reserve indices after various organ-sparing operations for uterine fibroids: hysteroresectoscopic (HRS) myomectomy, laparoscopic myomectomy, and uterine artery embolization (UAE). Subjects and methods. Ninety-two patients were examined; organ-sparing operations, such as laparoscopic and HRS myomectomies and UAE, were performed. All the examinees were divided into 3 groups: 1) 27 women after HRS myomectomy; 2) 42 patients after laparoscopic myomectomy; 3) 23 patients after UAE. A control group consisted of 20 healthy reproductive-aged women. Results. All surgical interventions lead to a significant decrease in the production of anti-Müllerian hormone (AMH) and estradiol in the presence of elevated luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels. HRS myomectomy results in a gradual restoration of ovarian reserve markers overtime at 4-6 months postsurgery. After laparoscopic myomectomy, the changes in the level of ovarian reserve markers were more pronounced and the production of gonadotropic and steroid hormones became normal at month 6 following surgery. After UAE, there was the most pronounced decline in the production of AMH and estradiol and an increase in the levels of LH and FSH; the production of AMH and estradiol significantly increased over time by the 6th postoperative month, but returned to the normal preoperative values only 10 months following surgery. Conclusion. UAE exerts the greatest impact on ovarian function, after which the changes in the hormonal status and blood flow in the uterus and ovaries remain for 10 months compared with 6 months after HRS and laparoscopic myomectomies.</p></abstract><trans-abstract xml:lang="ru"><p>Цель. Изучение состояния показателей овариального резерва после различных вариантов органосохраняющих операций при миоме матки: гистерорезектоскопической (ГРС) миомэктомии, миомэктомии лапароскопическим доступом и эмболизации маточных артерий (ЭМА). Материалы и методы. Обследованы 92 пациентки, были проведены следующие варианты органосохраняющих операций: лапароскопическая и ГРС-миомэктомия, ЭМА. Все обследованные пациентки были разделены на 3 группы: 1 группа - пациентки после ГРС-миомэктомии - 27 женщин; 2 группа - пациентки после лапароскопической миомэктомии - 42 женщины; 3 группа - пациентки после ЭМА - 23 пациентки. Контрольную группу составили 20 здоровых женщин репродуктивного возраста. Результаты. Все оперативные вмешательства приводят к достоверному снижению продукции антимюллерова гормона (АМГ) и эстрадиола на фоне повышения уровней лютеинизирующего гормона (ЛГ) и фолликулостимулирующего гормона (ФСГ). При проведении ГРС-миомэктомии в динамике происходит постепенное восстановление маркеров овариального резерва к 4-6 месяцу после операции. После операции миомэктомии, произведенной лапароскопическим доступом, изменения уровней маркеров овариального резерва были более выраженными, и показатели продукции гонадотропных и стероидных гормонов нормализовались к 6 месяцу послеоперационного периода. После ЭМА наблюдалось наиболее выраженное снижение продукции АМГ и эстрадиола и увеличение уровней ЛГ и ФСГ; к 6месяцу послеоперационного периода происходит достоверное увеличение продукции АМГ и эстрадиола в динамике, но до нормальных, дооперационных, показателей восстановление происходит лишь через 10месяцев после операции. Заключение. Наибольшее воздействие на функциональное состояние яичников оказывает ЭМА, изменения гормонального статуса и кровотока матки и яичников после которой остаются в течение 10 месяцев по сравнению с 6 месяцами после ГРС- и лапароскопической миомэктомии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>uterine myoma</kwd><kwd>hysteroresectoscopic myomectomy</kwd><kwd>laparoscopic myomectomy</kwd><kwd>uterine artery embolization</kwd><kwd>ovarian reserve</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>миома матки</kwd><kwd>гистерорезектоскопическая миомэктомия</kwd><kwd>лапароскопическая миомэктомия</kwd><kwd>эмболизация маточной артерии</kwd><kwd>овариальный резерв</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Dolmans M.M., Donnez J., Fellah L. Uterine fibroid management: Today and tomorrow. J. Obstet. Gynaecol. Res. 2019; 45(7): 1222-9. https://dx.doi. org/10.1111/jog.14002.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Agdi M., Tulandi T. Endoscopic management of uterine fibroids. Best Pract. Res. Clin. Obstet. Gynaecol. 2008; 22(4): 707-16. https://dx.doi.org/10.1016/). bpobgyn.2008.01.011.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Beyan E., Kanmaz A.G., Inan A.H., Karata§h V., Tutar S.O., Alan M. et al. Töz E, Sanci M. Evaluation of occult uterine leiomyosarcomas. Ginekol. Pol. 2019; 90(8): 433-7. https://dx.doi.org/10.5603/GP.2019.0075.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Arthur R., Kachura J., Liu G., Chan C., Shapiro H. Laparoscopic myomectomy versus uterine artery embolization: long-term impact on markers of ovarian reserve. J. Obstet. Gynaecol. Can. 2014; 36(3): 240-7. https://dx.doi. org/10.1016/S1701-2163(15)30632-0.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Practice Committee of the American Society for Reproductive medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil. Steril. 2012; 98(6): 1407-15. https://dx.doi.org/10.1016/j.fertnstert.2014.12.093.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Torre A., Fauconnier A., Kahn V., Limot O., Bussierres L., Pelage J.P. Fertility after uterine artery embolization for symptomatic multiple fibroids with no other infertility factors. Eur. Radiol. 2017; 27(7): 2850-9. https://dx.doi.org/10.1007/ s00330-016-4681-z.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Alessandri F., Lijoi D., Mistrangelo E., Ferrero S., Ragni N. Randomized study of laparoscopic versus minilaparotomic myomectomy for uterine myomas. J. Minim. Invasive Gynecol. 2006; 13(2): 92-7. https://dx.doi.org/10.1016/j. jmig.2005.11.008.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>American College of Obstetricians and Gynacologists. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet. Gynecol. 2008; 112(2, Pt 1): 387-400. https://dx.doi.org/10.1097/AOG.0b013e318183fbab.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Mara M.M., Maskova J., Fucikova Z., Kuzel D., Belsan T., Sosna O. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc. Intervent. Radiol. 2008; 31(1): 73-85. https://dx.doi.org/10.1007/s00270-007-9195-2.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Moss J., Cooper K., Khaund A., Murray L., Murray G., Wu O. et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG. 2011; 118(8): 936-44. https://dx.doi.org/10.1111/j.1471-0528.2011.02952.x.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>van der Kooij S.M., Hehenkamp W.J.K., Volkers N.A., Birnie E., Ankum W.M., Reekers J.A. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. Am. J. Obstet. Gynecol. 2010; 203(2): 105. e1-13. https://dx.doi. org/10.1016/j.ajog.2010.01.049.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Goodwin S.C., Spies J.B., Worthington-Kirsch R., Peterson E., Pron G., Li S. et al. Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID registry. Obstet. Gynecol. 2008; 111(1): 22-33. https:// dx.doi.org/10.1097/01.AOG.0000296526.71749.c9.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Ouyang Z., Liu P., Yu Y., Chen C., Song X., Liang B. et al. Role of ovarian artery-to-uterine artery anastomoses in uterine artery embolization: initial anatomic and radiologic studies. Surg. Radiol. Anat. 2012; 34(8): 737-41. https://dx.doi. org/10.1007/s00276-011-0883-x.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Ahmad A., Qadan L., Hassan N., Najarian K. Uterine artery embolization for treatment of uterine fibroids: Effect on ovarian function in younger women. J. Vasc. Interv. Radiol. 2002; 13(10): 1017-20. https://dx.doi.org/10.1016/s1051-0443(07)61866-1.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Spies J.B., Roth A.R., Gonsalves S.M., Murphy-Skrzyniarz K.M. Ovarian function after uterine artery embolization for leiomyomata: assessment with use of serum follicle stimulating hormone assay. J. Vasc. Interv. Radiol. 2001; 12(4): 437-42. https://dx.doi.org/10.1016/s1051-0443(07)61881-8.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>McLucas B., Danzer H., Wambach C., Lee C. Ovarian reserve following uterine artery embolization in women of reproductive age: a preliminary report. Minim. Invasive Ther. Allied Technol. 2013; 22(1): 45-9. https://dx.doi.org/10.3109/13 645706.2012.743918.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Hehenkamp W.J.K., Volkers N.A., Broekmans F.J.M., de Jong FH, Themmen A.P.N., Birnie E. et al. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum. Reprod 2007; 22(7): 1996-2005. https://dx.doi.org/10.1093/humrep/dem105.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Gupta J.K., Sinha A., Lumsden M.A., Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst. Rev. 2014; (12): CD005073. https://dx.doi.org/10.1002/14651858.CD005073.pub4.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Manyonda I.T., Bratby M., Horst J.S., Banu N., Gorti M., Belli A.M. Uterine artery embolization versus myomectomy: Impact on quality of life - results of the FUME (Fibroids of the uterus: Myomectomy versus embolization) trial. Cardiovasc. Intervent. Radiol. 2012; 35(3): 530-6. https://dx.doi.org/10.1007/ s00270-011-0228-5.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Jun F., Yamin L., Xinli X., Zhe L., Min Z., Bo Z., Wenli G. Uterine artery embolization versus surgery for symptomatic uterine fibroids: A randomized controlled trial and a meta-analysis of the literature. Arch. Gynecol. Obstet. 2012; 285(5): 1407-13. https://dx.doi.org/10.1007/s00404-011-2065-9.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Chrisman H.B., Saker M.B., Ryu R.K., Nemcek A.A. Jr., Gerbie M.V., Milad M.P. et al. The impact of uterine fibroid embolization on resumption of menses and ovarian function. J. Vasc. Interv. Radiol. 2010; 11(6): 699-703. https://dx.doi. org/10.1016/s1051-0443(07)61627-3.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Panagiotopoulou N., Nethra S., Karavolos S., Ahmad G., Karabis A, Burls A. Uterine-sparing minimally invasive interventions in women with uterine fibroids: A systematic review and indirect treatment comparison meta-analysis. Acta Obstet. Gynecol. Scand. 2014; 93(9): 858-67. https://dx.doi.org/10.1111/ aogs.12441.</mixed-citation></ref></ref-list></back></article>
